Alnylam Pharmaceuticals, Inc.【ALNY】業績推移・財務諸表

（単位：千ドル）	2Q10	3Q10	1Q11	2Q11	3Q11	1Q12	2Q12	3Q12	4Q12	1Q13	2Q13	3Q13	4Q13	1Q14	2Q14	3Q14	4Q14	1Q15	2Q15	3Q15	4Q15	1Q16	2Q16	3Q16	4Q16	1Q17	2Q17	3Q17	4Q17	1Q18	2Q18	3Q18	4Q18	1Q19	2Q19	3Q19	4Q19	1Q20	2Q20	3Q20	4Q20	1Q21	2Q21	3Q21	1Q22	2Q22	3Q22	1Q23	2Q23	3Q23	1Q24	2Q24	3Q24	1Q25
売上高	26,617	27,668	20,897	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29,907	2,069	21,033	33,294	44,714	70,061	71,681	99,476	103,962	125,853	163,562	177,566	220,553	187,633	213,259	224,818	264,306	319,290	318,754	750,530	494,333	659,825	500,919	594,189
売上成長率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
売上原価	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	137	-	3,347	4,326	5,213	-	13,302	19,929	21,797	-	23,023	30,256	28,091	23,457	34,038	36,507	41,432	75,336	79,473	54,613	67,271	81,980	70,183
研究開発費	28,136	27,468	26,349	25,303	24,274	21,074	-	22,094	-	22,179	24,215	34,457	-	43,758	44,672	46,273	-	58,035	67,007	68,618	-	96,273	83,172	97,936	-	86,984	90,627	95,252	-	96,857	137,582	139,945	-	129,127	163,890	160,796	-	169,571	154,996	161,783	-	185,899	182,635	194,572	169,893	205,712	245,371	230,569	248,526	253,179	260,995	294,142	270,926	265,122
販売管理費	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	116,545	-	89,608	112,769	120,351	-	126,761	127,896	167,472	-	146,859	145,323	142,075	154,471	169,984	235,859	183,659	214,689	199,175	210,797	248,397	220,993	239,949
営業費用	38,243	36,396	36,573	33,732	33,229	31,480	-	34,906	96,844	28,446	29,999	41,225	40,439	277,339	52,300	56,171	69,731	70,759	81,629	84,654	100,063	117,373	101,159	120,327	132,887	125,471	136,406	142,896	185,227	169,304	222,261	256,627	241,389	222,082	280,985	286,360	369,754	309,634	302,821	351,052	357,784	363,820	366,713	369,310	359,991	416,504	522,346	469,097	548,585	536,663	537,768	611,211	577,824	576,112
営業利益	-11,626	-8,728	-15,676	-13,118	-12,438	-10,893	-	-18,147	-	-9,804	-21,312	-32,234	-	-269,064	-45,005	-45,199	-	-52,222	-72,944	-78,330	-	-110,028	-92,450	-106,676	-	-106,511	-120,474	-125,800	-	-147,405	-192,354	-254,558	-	-188,788	-236,271	-216,299	-	-210,158	-198,859	-225,199	-	-186,254	-146,160	-181,677	-146,732	-191,686	-258,040	-149,807	-229,831	213,867	-43,435	48,614	-76,905	18,077
営業利益率 (%)				-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-			-				-				-
経常（税引前）利益	-14,861	-9,332	-16,285	-13,824	-13,237	-	-	-	-	-9,575	-21,053	-31,956	-	-268,813	-44,389	-43,922	-	-51,208	-71,352	-76,792	-	-102,974	-90,129	-	-	-	-	-	-	-141,276	-163,481	-244,837	-	-181,220	-218,521	-208,929	-	-181,646	-177,903	-252,452	-	-199,275	-188,331	-204,236	-239,356	-274,673	-405,943	-172,362	-274,209	150,741	-63,587	-11,167	-108,663	-41,596
経常（税引前）利益率（％）	-55.83	-33.73	-77.93	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-546.63	-11833.59	-	-544.3	-488.71	-298.21	-	-182.6	-171.12	-200.59	-	-112.23	-85.39	-108.85	-112.24	-122.18	-153.59	-53.98	-86.03	20.08	-12.86	-1.69	-21.69	-7.0
法人税等合計	-229	298	-	-	-	-	-	-	-	-562	-2,884	-2,270	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-62	79	445	-	695	960	-394	-	575	1,326	839	-	1,016	1,228	278	985	2,729	-23	1,739	1,815	2,988	2,348	5,722	2,907	15,883
実効税率（％）			-	-	-	-	-	-	-				-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-				-				-				-
純利益	-14,632	-9,630	-16,285	-13,824	-13,237	-11,368	-12,956	-19,502	-62,188	-9,013	-18,169	-29,686	-32,357	-250,943	-44,074	-43,989	-21,389	-50,777	-71,783	-76,792	-90,721	-102,974	-90,129	-104,071	-112,934	-107,290	-118,420	-122,937	-142,227	-141,214	-163,560	-245,282	-211,441	-181,915	-219,481	-208,535	-276,185	-182,221	-179,229	-253,291	-243,540	-200,291	-189,559	-204,514	-240,341	-277,402	-405,920	-174,101	-276,024	147,753	-65,935	-16,889	-111,570	-57,479
純利益率（％）				-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
一株あたり利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.61	-1.72	-2	-2.29	-3.32	-1.4	-2.21	1.18	-0.52	-0.13	-0.87	-0.44
希薄化後一株あたり利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.61	-1.72	-2	-2.29	-3.32	-1.4	-2.21	1.15	-0.52	-0.13	-0.87	-0.44
EBITDA	-	-		-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-		-	-		-	-		-	-
EBITDAマージン（％）	-	-		-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-		-	-	-		-	-	-		-	-		-	-		-	-		-	-

Alnylam Pharmaceuticals, Inc.【ALNY】 業績推移・財務諸表

Alnylam Pharmaceuticals, Inc.【ALNY】業績推移・財務諸表